Forteo (teriparatide) is a brand-name prescription medication used to treat osteoporosis [1]. It is a form of parathyroid hormone that helps to build bone [1].
How does Forteo work to build bone?
Forteo contains teriparatide, a synthetic version of human parathyroid hormone (PTH) [1]. When administered as an injection, teriparatide works by stimulating osteoblasts, which are bone-forming cells [2]. It also increases the rate of bone formation and enhances bone mineral density and bone strength [2]. This action helps to reduce the risk of fractures in individuals with osteoporosis [1].
What conditions is Forteo used to treat?
Forteo is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture. It is also used for men and women with osteoporosis at high risk for fracture who have failed or are intolerant to other available osteoporosis therapy. Additionally, it is prescribed for men and women with multiple fractures or other causes of osteoporotic fractures at high risk for fracture [1].
What is the typical dosage and administration of Forteo?
Forteo is administered as a subcutaneous injection, typically 20 micrograms once daily [1]. It is usually injected into the thigh or abdomen [3]. The recommended duration of treatment with Forteo is generally 24 months [1].
When does the patent for Forteo expire?
Patent expiration dates for pharmaceutical products are complex and can involve multiple patents. Information on the specific patent status and expected expiration for Forteo can be found on DrugPatentWatch.com [4].
Are there generic versions of Forteo available?
As patents expire, generic versions of medications can become available. The availability of generic teriparatide can impact pricing and market competition. DrugPatentWatch.com provides data on patent expiries and the potential for generic entry [4].
What are the potential side effects of Forteo?
Common side effects associated with Forteo injections include nausea, pain in the arms or legs, headache, and dizziness [1]. Less common but serious side effects can include an increased risk of osteosarcoma (bone cancer) in rats, although this risk has not been definitively established in humans [1]. Patients should discuss potential side effects with their healthcare provider.
How does Forteo compare to other osteoporosis treatments?
Forteo is considered a bone-building agent, distinct from treatments like bisphosphonates which primarily slow bone loss [2]. Its anabolic action makes it a valuable option for patients at high risk of fracture who may not respond adequately to other therapies.
What clinical data supports the use of Forteo?
Clinical trials have demonstrated Forteo's efficacy in reducing the risk of vertebral and non-vertebral fractures in postmenopausal women with osteoporosis [1]. Studies have shown significant increases in bone mineral density at the lumbar spine, total hip, and femoral neck following treatment [1].
Where can I find more information on Forteo's drug patents and exclusivity?
DrugPatentWatch.com offers detailed information regarding drug patents, including those for Forteo, as well as data on patent expiry dates and market exclusivity [4].
Sources:
[1] https://www.drugs.com/forteo.html
[2] https://www.ncbi.nlm.nih.gov/books/NBK279139/
[3] https://www.health.harvard.edu/diseases-and-conditions/what-to-know-about-osteoporosis-treatments
[4] https://drugpatentwatch.com/